Global Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2028

Segmentation

Short Description
Global Active Pharmaceutical Ingredients (API) Market, By Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS & Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028      

Market Definition:
In Greek, the traditional word for active pharmaceutical ingredients (API) is called pharmacon or pharmakon which symbolizes a magical substance or drug. Active pharmaceutical ingredients as described in ICH Q7 are any substance or combination of substances intended to be used in the manufacturing of a drug product which when used in the production of the drug becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity.

Market Segmentation:
The active pharmaceutical ingredients (API) market is segmented on the basis of the molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency and therapeutic application.
 On the basis of molecule, the active pharmaceutical ingredients (API) market is segmented into small molecule and large molecule
 On the basis of type, the active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients
 On the basis of type of manufacturer, the active pharmaceutical ingredients (API) market is segmented into captive API manufacturer and merchant API man
 On the basis of synthesis, the active pharmaceutical ingredients (API) market is segmented into synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients
 On the basis of chemical synthesis, the active pharmaceutical ingredients (API) market is segmented into acetaminophen, artemisinin, saxagliptin, sodium chloride, ibuprofen losartan potassium, enoxaparin sodium, rufinamide, naproxen, tamoxifen and others
 On the basis of type of drug, the active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs
 On the basis of usage, the active pharmaceutical ingredients (API) market is segmented into clinical and research
 On the basis of potency, the active pharmaceutical ingredients (API) market is segmented into low-to-moderate potency active pharmaceutical ingredients and potent-to-highly potent active pharmaceutical ingredient
 On the basis of therapeutic application, the active pharmaceutical ingredients (API) market is segmented into cardiology, CNS & neurology, oncology, orthopedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and other therapeutic application

Market Players:
The key market players for global active pharmaceutical ingredients (API) market are listed below:
 Dr. Reddys Laboratories Ltd.
 Sun Pharmaceutical Industries Ltd.
 Pfizer Inc.
 Sanofi
 GlaxoSmithKline plc
 AARTI INDUSTRIES LIMITED
 Recipharm AB  
 Jubilant Pharmova Limited
 LUPIN
 Aurobindo Pharma
 Alembic Pharmaceuticals Limited
 AbbVie Inc.
 AstraZeneca
 Alkem Labs
 Albemarle Corporation
 Saneca Pharmaceuticals
 Unichem Laboratories
 Neuland Laboratories Ltd.
 Divi's Laboratories Limited
 HIKAL Ltd.
 Viatris Inc.
 Merck KGaA
 Novo Nordisk A/S
 Sandoz International GmbH (a subsidiary of Novartis AG)
 Teva Pharmaceutical Industries Ltd.
 Minakem
 BASF SE
 Cipla Inc.
 CordenPharma International
 Piramal Pharma Solutions

Methodology